{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:31:57Z","timestamp":1764502317566,"version":"3.46.0"},"reference-count":18,"publisher":"Practical Medicine Publishing House","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Background &amp; Aims.\u00a0The chimeric tyrosine kinase Bcr-Abl triggers malignant transformation of myeloid cells via phosphorylation of a number of substrates including the CrkL adaptor protein. Pharmacological inhibition of Bcr-Abl mediated signaling is a major strategy in treatment of patients with chronic myeloid leukemia (CML). A new specific Bcr-Abl inhibitor (PF-114) was designed using a molecular modeling approach. The paper defines the cytotoxicity of PF-114 against CML cells and its effect on the CrkL phosphorylation.\r\nMethods.\u00a0The cytotoxicity was determined using the MTT assay. The total intracellular CrKL pool (phosphorylated and non-phosphorylated forms) was determined by means of flow cytometry.\r\nResults.\u00a0Exposure of Bcr-Abl-positive, K562 cell line to PF-114 blocked intracellular CrkL phosphorylation and caused cell death. In contrast, virtually no phosphorylated CrkL was detectable in Bcr-Abl-negative HL60, U937 and Jurkat leukemia cell lines.\r\nConclusion.\u00a0Absence of phosphorylation in Bcr-Abl-negative cells (HL60, U937 and Jurkat) and death of HL60 cells under the effect of PF-114 at concentrations exceeding those required to kill K562 cells supports the emergence of PF-114 as a promising drug candidate for CML.<\/jats:p>","DOI":"10.21320\/2500-2139-2016-9-1-1-5","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T20:09:49Z","timestamp":1463861389000},"page":"1-5","source":"Crossref","is-referenced-by-count":0,"title":["PF-114, a Novel Inhibitor of Bcr-Abl Chimeric Tyrosine Kinase, Attenuates Intracellular CrkL Phosphorylation and Kills Chronic Myeloid Leukemia Cells","PF-114, \u043d\u043e\u0432\u044b\u0439 \u0438\u043d\u0433\u0438\u0431\u0438\u0442\u043e\u0440 \u0442\u0438\u0440\u043e\u0437\u0438\u043d\u043a\u0438\u043d\u0430\u0437\u044b Bcr-Abl, \u0441\u043d\u0438\u0436\u0430\u0435\u0442 \u0444\u043e\u0441\u0444\u043e\u0440\u0438\u043b\u0438\u0440\u043e\u0432\u0430\u043d\u0438\u0435 CrkL \u0438 \u0432\u044b\u0437\u044b\u0432\u0430\u0435\u0442 \u0433\u0438\u0431\u0435\u043b\u044c \u043a\u043b\u0435\u0442\u043e\u043a \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u043c\u0438\u0435\u043b\u043e\u0438\u0434\u043d\u043e\u0433\u043e \u043b\u0435\u0439\u043a\u043e\u0437\u0430"],"prefix":"10.21320","volume":"9","author":[{"given":"E. S.","family":"Kolotova","sequence":"first","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. V.","family":"Tatarskii","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Zeifman","sequence":"additional","affiliation":[{"name":"N.D. Zelinskii Institute of Organic Chemistry, 47 Leninskii pr-t, Moscow, Russian Federation, 119991; Fusion Pharma, 18 bld. 2 Generala Dorokhova str., Moscow, Russian Federation, 119530"},{"name":"\u0424\u0413\u0411\u0423\u041d \u00ab\u0418\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u043e\u0440\u0433\u0430\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0445\u0438\u043c\u0438\u0438 \u0438\u043c. \u041d.\u0414. \u0417\u0435\u043b\u0438\u043d\u0441\u043a\u043e\u0433\u043e\u00bb \u0420\u0410\u041d, \u041b\u0435\u043d\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0442, \u0434. 47, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119991; \u041e\u041e\u041e \u00ab\u0424\u044c\u044e\u0436\u043d \u0424\u0430\u0440\u043c\u0430\u00bb, \u0443\u043b. \u0413\u0435\u043d\u0435\u0440\u0430\u043b\u0430 \u0414\u043e\u0440\u043e\u0445\u043e\u0432\u0430, \u0434. 18, \u0441\u0442\u0440. 2, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119530"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. V.","family":"Stroganov","sequence":"additional","affiliation":[{"name":"N.D. Zelinskii Institute of Organic Chemistry, 47 Leninskii pr-t, Moscow, Russian Federation, 119991; Fusion Pharma, 18 bld. 2 Generala Dorokhova str., Moscow, Russian Federation, 119530"},{"name":"\u0424\u0413\u0411\u0423\u041d \u00ab\u0418\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u043e\u0440\u0433\u0430\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0445\u0438\u043c\u0438\u0438 \u0438\u043c. \u041d.\u0414. \u0417\u0435\u043b\u0438\u043d\u0441\u043a\u043e\u0433\u043e\u00bb \u0420\u0410\u041d, \u041b\u0435\u043d\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0442, \u0434. 47, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119991; \u041e\u041e\u041e \u00ab\u0424\u044c\u044e\u0436\u043d \u0424\u0430\u0440\u043c\u0430\u00bb, \u0443\u043b. \u0413\u0435\u043d\u0435\u0440\u0430\u043b\u0430 \u0414\u043e\u0440\u043e\u0445\u043e\u0432\u0430, \u0434. 18, \u0441\u0442\u0440. 2, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119530"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. S.","family":"Stroilov","sequence":"additional","affiliation":[{"name":"N.D. Zelinskii Institute of Organic Chemistry, 47 Leninskii pr-t, Moscow, Russian Federation, 119991; Fusion Pharma, 18 bld. 2 Generala Dorokhova str., Moscow, Russian Federation, 119530"},{"name":"\u0424\u0413\u0411\u0423\u041d \u00ab\u0418\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u043e\u0440\u0433\u0430\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0445\u0438\u043c\u0438\u0438 \u0438\u043c. \u041d.\u0414. \u0417\u0435\u043b\u0438\u043d\u0441\u043a\u043e\u0433\u043e\u00bb \u0420\u0410\u041d, \u041b\u0435\u043d\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0442, \u0434. 47, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119991; \u041e\u041e\u041e \u00ab\u0424\u044c\u044e\u0436\u043d \u0424\u0430\u0440\u043c\u0430\u00bb, \u0443\u043b. \u0413\u0435\u043d\u0435\u0440\u0430\u043b\u0430 \u0414\u043e\u0440\u043e\u0445\u043e\u0432\u0430, \u0434. 18, \u0441\u0442\u0440. 2, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119530"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Yu.","family":"Titov","sequence":"additional","affiliation":[{"name":"N.D. Zelinskii Institute of Organic Chemistry, 47 Leninskii pr-t, Moscow, Russian Federation, 119991; Fusion Pharma, 18 bld. 2 Generala Dorokhova str., Moscow, Russian Federation, 119530"},{"name":"\u0424\u0413\u0411\u0423\u041d \u00ab\u0418\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u043e\u0440\u0433\u0430\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0445\u0438\u043c\u0438\u0438 \u0438\u043c. \u041d.\u0414. \u0417\u0435\u043b\u0438\u043d\u0441\u043a\u043e\u0433\u043e\u00bb \u0420\u0410\u041d, \u041b\u0435\u043d\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0442, \u0434. 47, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119991; \u041e\u041e\u041e \u00ab\u0424\u044c\u044e\u0436\u043d \u0424\u0430\u0440\u043c\u0430\u00bb, \u0443\u043b. \u0413\u0435\u043d\u0435\u0440\u0430\u043b\u0430 \u0414\u043e\u0440\u043e\u0445\u043e\u0432\u0430, \u0434. 18, \u0441\u0442\u0440. 2, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119530"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. N.","family":"Novikov","sequence":"additional","affiliation":[{"name":"N.D. Zelinskii Institute of Organic Chemistry, 47 Leninskii pr-t, Moscow, Russian Federation, 119991; Fusion Pharma, 18 bld. 2 Generala Dorokhova str., Moscow, Russian Federation, 119530"},{"name":"\u0424\u0413\u0411\u0423\u041d \u00ab\u0418\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u043e\u0440\u0433\u0430\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0445\u0438\u043c\u0438\u0438 \u0438\u043c. \u041d.\u0414. \u0417\u0435\u043b\u0438\u043d\u0441\u043a\u043e\u0433\u043e\u00bb \u0420\u0410\u041d, \u041b\u0435\u043d\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0442, \u0434. 47, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119991; \u041e\u041e\u041e \u00ab\u0424\u044c\u044e\u0436\u043d \u0424\u0430\u0440\u043c\u0430\u00bb, \u0443\u043b. \u0413\u0435\u043d\u0435\u0440\u0430\u043b\u0430 \u0414\u043e\u0440\u043e\u0445\u043e\u0432\u0430, \u0434. 18, \u0441\u0442\u0440. 2, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119530"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Kalinina","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. G.","family":"Chilov","sequence":"additional","affiliation":[{"name":"N.D. Zelinskii Institute of Organic Chemistry, 47 Leninskii pr-t, Moscow, Russian Federation, 119991; Fusion Pharma, 18 bld. 2 Generala Dorokhova str., Moscow, Russian Federation, 119530"},{"name":"\u0424\u0413\u0411\u0423\u041d \u00ab\u0418\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u043e\u0440\u0433\u0430\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0445\u0438\u043c\u0438\u0438 \u0438\u043c. \u041d.\u0414. \u0417\u0435\u043b\u0438\u043d\u0441\u043a\u043e\u0433\u043e\u00bb \u0420\u0410\u041d, \u041b\u0435\u043d\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0442, \u0434. 47, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119991; \u041e\u041e\u041e \u00ab\u0424\u044c\u044e\u0436\u043d \u0424\u0430\u0440\u043c\u0430\u00bb, \u0443\u043b. \u0413\u0435\u043d\u0435\u0440\u0430\u043b\u0430 \u0414\u043e\u0440\u043e\u0445\u043e\u0432\u0430, \u0434. 18, \u0441\u0442\u0440. 2, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 119530"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr Al\u2019bertovich","family":"Shtil\u2019","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"doi-asserted-by":"publisher","key":"16339","DOI":"10.1517\/14656566.2015.1031107"},{"doi-asserted-by":"publisher","key":"16340","DOI":"10.1371\/journal.pone.0133590"},{"doi-asserted-by":"publisher","key":"16341","DOI":"10.1074\/jbc.R112.438382"},{"unstructured":"\u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043e\u043d\u043a\u043e\u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f: \u0420\u0443\u043a\u043e\u0432\u043e\u0434\u0441\u0442\u0432\u043e \u0434\u043b\u044f \u0432\u0440\u0430\u0447\u0435\u0439. \u041f\u043e\u0434 \u0440\u0435\u0434. \u041c.\u0410. \u0412\u043e\u043b\u043a\u043e\u0432\u043e\u0439. 2-\u0435 \u0438\u0437\u0434., \u043f\u0435\u0440\u0435\u0440\u0430\u0431. \u0438 \u0434\u043e\u043f. \u041c.: \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0430, 2007. \u0421. 555.","key":"16342"},{"unstructured":"[Volkova MA, ed. Klinicheskaya onkogematologiya: Rukovodstvo dlya vrachei. (Clinical oncohematology: guidelines for doctors.) 2nd revised edition. Moscow: Meditsina Publ.; 2007. p. 555 (In Russ)]","key":"16343"},{"doi-asserted-by":"publisher","key":"16344","DOI":"10.1371\/journal.pone.0028395"},{"doi-asserted-by":"publisher","key":"16345","DOI":"10.1182\/blood.V84.9.2912.bloodjournal8492912"},{"doi-asserted-by":"publisher","key":"16346","DOI":"10.18632\/oncotarget.2278"},{"doi-asserted-by":"publisher","key":"16347","DOI":"10.1111\/j.1365-2141.2009.08066.x"},{"doi-asserted-by":"publisher","key":"16348","DOI":"10.1056\/NEJMoa022457"},{"doi-asserted-by":"publisher","key":"16349","DOI":"10.1182\/blood-2013-05-501569"},{"doi-asserted-by":"publisher","key":"16350","DOI":"10.1056\/NEJMoa1205127"},{"doi-asserted-by":"publisher","key":"16351","DOI":"10.1038\/leu.2014.326"},{"doi-asserted-by":"publisher","key":"16352","DOI":"10.1038\/sj.leu.2404189"},{"unstructured":"Knebel A. Kinasource protein kinase substrate screen KESTREL. Available from: (accessed 21.03.2016).","key":"16353"},{"doi-asserted-by":"publisher","key":"16354","DOI":"10.1083\/jcb.200311045"},{"doi-asserted-by":"publisher","key":"16355","DOI":"10.18632\/oncotarget.2072"},{"doi-asserted-by":"publisher","key":"16356","DOI":"10.1002\/pmic.200600109"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/460\/426","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/460\/426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:30:07Z","timestamp":1764502207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2016-9-1-1-5","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"type":"electronic","value":"2500-2139"},{"type":"print","value":"1997-6933"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}